Innate Pharma SA

Затворен

1.552 -1.27

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.486

Максимум

1.572

Ключови измерители

By Trading Economics

Приходи

-6.5M

-28M

Продажби

-6.9M

-2.1M

EPS

-0.12

Марж на печалбата

1,342.644

Служители

164

EBITDA

-5.9M

-31M

Дивиденти

By Acuity

Следващи печалби

16.09.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

48M

158M

Предишно отваряне

2.82

Предишно затваряне

1.552

Innate Pharma SA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.06.2026 г., 23:56 ч. UTC

ETF Constituents
Correlated Moves
Macro News

The Consumer Discretionary Select Sector SPDR Fund declined after the U.S. core PCE price index rose, exceeding the Federal Reserve's target and impacting sentiment.

25.06.2026 г., 23:56 ч. UTC

Gilead Sciences shares moved higher in after-market hours, despite earlier declines during regular trading amid mixed U.S. market performance influenced by economic data.

25.06.2026 г., 23:52 ч. UTC

U.S. equity markets show mixed results amid inflation concerns and stronger-than-expected GDP growth, while the dollar strengthens as Treasury yields drive forex dynamics.

25.06.2026 г., 23:52 ч. UTC

European equity markets rise on strong tech earnings, while UK retail struggles and France sees improved consumer confidence amidst mixed economic signals.

25.06.2026 г., 23:52 ч. UTC

Global markets show mixed performance as U.S. tech stocks lag despite strong job data and GDP growth, while Japan's Nikkei rises on positive earnings.

25.06.2026 г., 23:52 ч. UTC

Mixed Asia equity markets as Japan's Nikkei rises 4.3% on strong tech earnings, while U.S. jobless claims drop and GDP growth is revised up, amid persistent inflation concerns.

25.06.2026 г., 23:52 ч. UTC

Macro News

The Nikkei 225 Index is lower in after-market hours amid yen weakness and rising geopolitical tensions affecting investor sentiment.

25.06.2026 г., 23:51 ч. UTC

Incyte Corp shares are higher in after-market hours, recovering from an earlier session low. Broader market performance remains mixed amid varying tech stock results.

25.06.2026 г., 23:51 ч. UTC

Monster Beverage Corp. shares are lower in after-market trading, continuing a decline since Thursday's close, despite remaining above the 20-day moving average.

25.06.2026 г., 23:51 ч. UTC

Electronic Arts Inc. shares are lower in after-market trading amid notable weakness in the Interactive Home Entertainment sub-sector. No specific news was identified.

25.06.2026 г., 23:51 ч. UTC

Charter Communications Inc shares are higher in after-market hours, recovering from an earlier dip. The stock remains below its 20-day moving average.

25.06.2026 г., 23:51 ч. UTC

Market Anticipates Positive Job Growth in Upcoming ADP Employment Report Amid Optimistic Labor Market Sentiment and Inflation Concerns.

25.06.2026 г., 23:51 ч. UTC

American Airlines shares are lower in after-market hours, with no specific news identified. The broader market showed mixed performance following Thursday's close.

25.06.2026 г., 23:51 ч. UTC

Correlated Moves
Macro News

The S&P 500 Index is lower today amid a securities fraud lawsuit against Zillow and rising geopolitical tensions affecting market sentiment.

25.06.2026 г., 23:51 ч. UTC

Workday Inc shares are higher in after-market trading, driven by gains in the Application Software sub-sector. The stock has recovered from earlier lows.

25.06.2026 г., 23:51 ч. UTC

Correlated Moves
Social Media

Applied Materials shares are higher in after-market hours following Citi's price target increase to 710 and positive sentiment in the semiconductor equipment sector.

25.06.2026 г., 23:51 ч. UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

25.06.2026 г., 23:51 ч. UTC

ETF Constituents

iShares Biotechnology ETF is higher in after-market trading, supported by gains from Vertex Pharmaceuticals, Gilead Sciences, and Incyte Corporation among others.

25.06.2026 г., 23:51 ч. UTC

T-Mobile US Inc shares are higher in after-market hours, showing unusual strength amid mixed broader market performance with no specific news identified.

25.06.2026 г., 23:51 ч. UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

25.06.2026 г., 23:51 ч. UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

25.06.2026 г., 23:51 ч. UTC

The EUR/HUF is lower in Thursday's session amid ongoing market volatility. The currency pair briefly gained before declining without a specific identified driver.

25.06.2026 г., 23:51 ч. UTC

Correlated Moves

Ethereum is trading lower, continuing a four-session decline amid significant volatility. It remains under pressure, well below its 20-day moving average.

25.06.2026 г., 23:51 ч. UTC

Social Media
Correlated Moves

Broadcom Inc. shares were roughly flat in after-market trading, continuing a trend of decline this month, contrasting with gains among other large S&P 500 stocks.

25.06.2026 г., 23:51 ч. UTC

NetEase Inc shares are higher in after-market hours following Thursday's close, despite remaining below the 20-day moving average. No specific news was identified.

25.06.2026 г., 23:46 ч. UTC

Correlated Moves

Vanguard Total International Bond ETF trades near unchanged after hours, reflecting stable performance amid slight declines in the US 10Y Treasury Bond.

25.06.2026 г., 23:46 ч. UTC

Correlated Moves

iShares TIPS Bond ETF remains flat in after-hours trading, reflecting stability amid a slight increase in the iShares iBoxx $ High Yield Corporate Bond ETF.

25.06.2026 г., 23:46 ч. UTC

ETF Constituents
Correlated Moves

Health Care Select Sector SPDR Fund declines in after-market hours, reflecting broader market trends. Key holdings Zoetis and Baxter contribute negatively to performance.

25.06.2026 г., 23:46 ч. UTC

SPDR Gold Shares are trading lower in after-market hours, remaining below the 20-day moving average and near the lower end of its one-month trading range.

25.06.2026 г., 23:46 ч. UTC

PayPal Holdings Inc shares are higher in after-market trading, influenced by strong earnings from Micron Technology amid a mixed tech sector performance.

Сравнение с други в отрасъла

Ценова промяна

Innate Pharma SA Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Innate Pharma SA

Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France.
help-icon Live chat